APA (7th ed.) Citation

AT, K., F, P., M, F., T, L., S, Z., A, Z., . . . AT, G. (2026). Ruxolitinib treatment for myelofibrosis with anemia: A retrospective assessment of real-world patient characteristics, treatment patterns, and survival. Leukemia & lymphoma, 67(5), 1088. https://doi.org/10.1080/10428194.2026.2628361

Chicago Style (17th ed.) Citation

AT, Kuykendall, et al. "Ruxolitinib Treatment for Myelofibrosis with Anemia: A Retrospective Assessment of Real-world Patient Characteristics, Treatment Patterns, and Survival." Leukemia & Lymphoma 67, no. 5 (2026): 1088. https://doi.org/10.1080/10428194.2026.2628361.

MLA (9th ed.) Citation

AT, Kuykendall, et al. "Ruxolitinib Treatment for Myelofibrosis with Anemia: A Retrospective Assessment of Real-world Patient Characteristics, Treatment Patterns, and Survival." Leukemia & Lymphoma, vol. 67, no. 5, 2026, p. 1088, https://doi.org/10.1080/10428194.2026.2628361.